Search - tctmd.com

Displaying 781 - 800 of 1588

Sort: Relevancy | Date

Presentation TCT 2018

All-Cause Mortality and Interpretation of Secondary Endpoints: The VEST and ODYSSEY Examples

Presenter: E. Magnus Ohman, Stuart J. Pocock

September 23, 2018

Presentation TCT 2018

What Are the Lasting Clinical Implications Of the ORBITA Trial?

Presenter: Anibal A. Damonte, Diego D Grinfeld, Alfredo E. Rodriguez, John A. Ambrose

September 23, 2018

Presentation TCT 2018

Patient Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall

September 23, 2018

News Conference News TCT 2018

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Todd Neale

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

FDA Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry

September 23, 2018

Presentation TCT 2018

ISCHEMIA Trial in the Spotlight: Why All the Fuss Over the Change in the Primary Endpoint?

Presenter: E. Magnus Ohman, Stuart J. Pocock, David J. Maron

September 23, 2018

Presentation TCT 2018

Composite Endpoints: When Are They Valid and When Should They Be Discarded

Presenter: E. Magnus Ohman, Stuart J. Pocock, Sanjay Kaul

September 23, 2018

Presentation TCT 2018

PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension

Presenter: Valentin Fuster, Shao-Liang Chen

September 23, 2018

Presentation TCT 2018

Clinical Trial Considerations for Transcatheter TR Therapies

Presenter: Ori Ben-Yehuda

September 23, 2018

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

Presentation TCT 2018

Trialign Pioneering Work Technology and Clinical Updates

Presenter: Christopher U. Meduri

September 23, 2018

News Conference News TCT 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Michael O'Riordan

September 22, 2018

News Opinion Off Script TCT 2018

Off Script: Sharing, Caring, and Daring to Dream

Kwan S. Lee

September 22, 2018

Presentation TCT 2018

ReCre8: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Pieter R. Stella

September 22, 2018

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

Presentation TCT 2018

TALENT: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Patrick W. Serruys

September 22, 2018

Presentation TCT 2018

BIONYX: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Clemens von Birgelen

September 22, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

Advertisement

All-Cause Mortality and Interpretation of Secondary Endpoints: The VEST and ODYSSEY Examples

What Are the Lasting Clinical Implications Of the ORBITA Trial?

Patient Perspectives on Sham-Controlled Trials

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

High Mortality but Durable Results With Valve-in-Valve TAVR

FDA Perspectives on Sham-Controlled Trials

ISCHEMIA Trial in the Spotlight: Why All the Fuss Over the Change in the Primary Endpoint?

Composite Endpoints: When Are They Valid and When Should They Be Discarded

PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension

Clinical Trial Considerations for Transcatheter TR Therapies

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Trialign Pioneering Work Technology and Clinical Updates

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Off Script: Sharing, Caring, and Daring to Dream

ReCre8: Summary and Clinical Implications

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

TALENT: Summary and Clinical Implications

BIONYX: Summary and Clinical Implications

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content